Compositions and methods for treating patients with RTK mutant cells

• 收藏
• 分享

专利权人:

Ignyta; Inc.

发明人:

Wei, Ge

申请号：

AU2016270321

公开号：

AU2016270321A1

申请日:

2016.05.25

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

Disclosed herein are compositions and methods for treating cancer patients who have been previously treated with one or more chemotherapeutic agents and have developed at least partial resistance to such chemotherapeutic agents. Also disclosed are methods for selecting compounds suitable for treatment of cancer in a patient who has become resistant to an inhibitor of a receptor tyrosine kinase (RTK).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/